CRITICalNCT07246525
Intermittent Preventive Treatment of Malaria in School-age Children to Decrease Community Transmission
StatusRecruiting
PhasePhase 4
Primary completion (estimated)
At risk: Primary completion moved at least 2 months later across 2 updates.
See at-risk trials from University of California, San Francisco
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
Notable Recruitment opened Show 5 more changesShow less
- Eligibility criteria expanded, about 4 words
- Primary and study completion pushed from Sep 30, 2029 to Nov 15, 2029
- Start date changed from estimate of Sep 28, 2026 to Sep 22, 2026
- Secondary endpoints: details revised at 3 of 13 entries
- Site details revised
- Notable Start date: Aug 1, 2026 to Sep 28, 2026
- Primary and study completion pushed from Aug 31, 2029 to Sep 30, 2029
- Notable Start date: May 1, 2026 to Aug 1, 2026
- Primary and study completion pushed from May 31, 2029 to Aug 31, 2029
- Notable Start date: Dec 1, 2025 to May 1, 2026v2
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Number of cases of laboratory-confirmed malaria diagnosed among patients residing in the target area during the period the intervention is implemented
Timeframe: 24 months after intervention implemented
Secondary (13)
Number of cases of laboratory-confirmed malaria diagnosed among patients residing in the target area after the intervention is competed
Parasite prevalence among community residents 12 months after the intervention is implemented
Parasite prevalence among community residents 24 months after the intervention is implemented
Parasite prevalence among community residents 12 months after the intervention is completed
Prevalence of molecular markers of DP resistance from parasite positive samples from community surveys 12 months after the intervention is implemented
Show 8 moreShow less
Prevalence of molecular markers of DP resistance from parasite positive samples from community surveys 24 months after the intervention is implemented
Prevalence of molecular markers of DP resistance from parasite positive samples from community surveys 12 months after the intervention is completed
Parasite prevalence among schoolchildren 12 months after the intervention is implemented
Parasite prevalence among schoolchildren 24 months after the intervention is implemented
Parasite prevalence among schoolchildren 12 months after the intervention is completed
Anemia prevalence among schoolchildren 12 months after the intervention is implemented
Anemia prevalence among schoolchildren 24 months after the intervention is implemented
Anemia prevalence among schoolchildren 12 months after the intervention is completed
Arms and interventions
IPTscExperimental
DP will be administered approximately every 2 months for two years to all eligible children enrolled in primary schools serving the target areas from clusters randomized to the interventional arm.
No IPTscNo intervention
No IPTsc (standard of care)
Drugs: dihydroartemisinin-piperaquine
Sites
1 site in 1 country
- Infectious Diseases Research CollaborationKampala, Uganda